Profiles of Expression in HPV+ Versus HPV Head and Neck Cancers

计划入组 60 人 · 首次发布于 2023 年 11 月 15 日

Study of Mucosal Sparing Adjuvant Radiotherapy After Surgical Exploration in HPV+ Head and Neck Cancer of Unknown Primaries

计划入组 2 人 · 首次发布于 2020 年 7 月 28 日

A Study Comparing Two Immunotherapy Options for Human Papillomavirus Positive HPV-Positive Head and Neck Cancer After Treatment

计划入组 68 人 · 首次发布于 2025 年 9 月 17 日

HPV-related head and neck cancer vaccine(Shanghai Yinuoruikang Biomedical Technology)

Head and Neck Cancer(Diakonos)

AGM-130

Danish Head And Neck Cancer Group

UNC Dermatology and Skin Cancer Center

United States

Fujian Cancer Hospital (Fujian Cancer Institute, Fujian Cancer Prevention and Treatment Center)

China

Outrun Therapeutics Advances First-in-Class E6AP Inhibitor for HPV-Positive Head and Neck Cancer

Aprea Therapeutics Advances APR-1051 Clinical Trial with First HPV+ Head and Neck Cancer Patient Dosed

BioNTech's BNT113 mRNA Cancer Vaccine Advances in Phase 2 Trial for HPV+ Head and Neck Cancer